FINANCIAL NEWS BRIEF
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
CNBC ·
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
This is a publisher-supplied news summary, not the full article. News briefs remain in our archive for 14 days after publication.